• Print

released: 13 Aug 2007 author: AIHW

The National Diabetes Data Working Group's Diabetes Indicators Review Sub-Committee, under the direction of the National Diabetes Strategies Group (NDSG), has developed a national set of thirty-three diabetes indicators. Of these indicators, eleven have been selected as the highest priority and endorsed by the NDSG. This report describes the process undertaken by the Sub-Committee in developing and prioritising the full set of indicators, and provides operational definitions for the recommended set of eleven indicators. The indicators address the NDSG's priorities for diabetes information including the prevention, detection, care and impact of diabetes in Australia.

ISSN 1444-8033; ISBN 978 1 74024 713 9; Cat. no. CVD 38; 114pp.; Internet only

Full publication

Publication table of contents

  • Preliminary material (205KB PDF)
    • Half title and verso pages
    • Title and verso pages
    • Contents
    • Acknowledgments
      • Membership of the Diabetes Indicators Review Subcommittee of the National Diabetes Data Working Group
    • Abbreviations
    • Executive summary
  • Sections
    • Introduction (186KB PDF)
      • Purpose of report
      • Indicators
      • Policy context for diabetes indicator development
      • Existing diabetes indicator sets
      • Why was a new set of diabetes indicators developed?
      • The recommended priority diabetes indicators
      • How do the recommended indicators complement Australian Government initiatives for chronic disease and diabetes?
    • Operational definitions for the recommended 11 indicators (559KB PDF)
      1. Prevalence of Type 2 modifiable diabetes risk factors over time
        1. Prevalence of overweight and obesity over time
        2. Proportion of people not following guidelines for physical activity over time
        3. Proportion of people not following Australian dietary recommendations over time
      2. The proportion of people at risk of Type 2 diabetes who correctly identify that they are at risk and who are taking steps/actions to reduce their risk
      3. The proportion of people at risk of Type 2 diabetes who are being opportunistically screened, and the proportion of these undergoing appropriate opportunistic screening (as defined by current evidence-based guidelines)
        1. The proportion of people at risk of Type 2 diabetes who are being opportunistically screened
        2. The proportion of people at risk of Type 2 diabetes who are undergoing appropriate opportunistic screening (as defined by current evidence-based guidelines)
      4. The number and characteristics of diabetes and at-risk programs, initiatives and services
      5. Ability for people to access services that are culturally suitable
      6. The number and characteristics of Type 1, Type 2 and gestational diabetes guidelines identified
      7. The proportion of people with diabetes mellitus who have had an annual cycle of care
      8. The proportion of people with diabetes who meet guideline targets for: HbA1c; blood pressure; cholesterol; and weight/BMI
        1. Proportion of people who meet guideline targets for HbA1c
        2. Proportion of people who meet guideline targets for blood pressure
        3. Proportion of people who meet guideline targets for cholesterol
        4. Proportion of people who meet guideline targets for weight/body mass index
      9. Diabetes-related death rate over time
      10. Quality of life of people with diabetes (measured by standardised questionnaire)
      11. Prevalence and incidence of diabetes, its complications and comorbidities over time
        1. Prevalence of diabetes over time
        2. Incidence of diabetes over time
        3. Prevalence of cardiovascular disease among people with diabetes over time
        4. Incidence of cardiovascular disease among people with diabetes over time
        5. Prevalence of visual loss among people with diabetes over time
        6. Incidence of visual loss among people with diabetes over time
        7. Prevalence of end-stage kidney disease among people with diabetes over time
        8. Incidence of end-stage kidney disease among people with diabetes over time
        9. Prevalence of non-traumatic amputation among people with diabetes over time
        10. Incidence of non-traumatic amputation among people with diabetes over time
    • Recommendations (100KB PDF)
  • End matter (323KB PDF)
    • Appendixes
      1. Complete indicator matrix
      2. National Health Priority Areas - diabetes indicators
      3. List of jurisdictions and consumers consulted
    • References
    • List of tables
    • List of boxes

Recommended citation

AIHW 2007. National indicators for monitoring diabetes: report of the Diabetes Indicators Review Subcommittee of the National Diabetes Data Working Group. Cat. no. CVD 38. Canberra: AIHW. Viewed 24 April 2014 <http://www.aihw.gov.au/publication-detail/?id=6442468011>.